Reducing Diagnostic Errors Worldwide Through Diagnostic Management Teams
- PMID: 30430773
- PMCID: PMC6240519
- DOI: 10.3343/alm.2019.39.2.121
Reducing Diagnostic Errors Worldwide Through Diagnostic Management Teams
Abstract
A major challenge facing most countries is the growing cost of healthcare. Laboratory testing costs constitute approximately 3% of all clinical costs, while waste of funds due to inappropriate admissions to clinical departments is reported to be as high as 15%. A frequently used approach to save money in healthcare is random reduction of laboratory budgets, focusing on decreasing the number of unnecessary laboratory tests. The World Health Assembly has approached this problem by publishing a list of essential in vitro diagnostic tests, to achieve a global rationalization of the problem. A much more thoughtful strategy to reducing healthcare expenditure is to improve the efficiency of the diagnostic process. Decreasing the time to a correct diagnosis provides considerable financial and clinical benefits. Additionally, reducing both overutilization and underutilization of laboratory tests while achieving the correct diagnosis is of great benefit to challenged healthcare budgets. Examining the situation in the United States and Italy, this review presents an opportunity for reducing diagnostic error and increasing the efficiency of diagnostic testing worldwide. One approach taken to achieve major savings in healthcare in the United States, which can be applied in Italy and other countries, is the creation of "diagnostic management teams," comprising experts in specialty areas of medicine, primarily based in the clinical laboratory, who can advise physicians on the selection of necessary tests and the interpretation of complex test results.
Keywords: Clinical laboratory; Diagnosis; Diagnostic error; Diagnostic management team.
© The Korean Society for Laboratory Medicine.
Conflict of interest statement
No potential conflicts of interest relevant to this article are reported.
Figures
References
-
- Essue BM, Laba M, et al. Economic burden of chronic ill health and injuries for households in low- and middle-income countries. In: Jamison DT, Gelband H, et al., editors. Disease control priorities: improving health and reducing poverty. 3rd ed. Washington (DC): The International Bank for Reconstruction and Development/The World Bank; 2017. pp. 121–146. - PubMed
-
- World Health Organization. World Health Organization model list of essential in vitro diagnostics. 1st ed. [Updated on Jun 2018]. http://www.who.int/medical_devices/diagnostics/WHO_EDL_2018.pdf.
-
- World Health Organization. Selection, access and use of in vitro diagnostics. [Updated on Jun 2018]. http://www.who.int/medical_devices/diagnostics/Selection_in-vitro_diagno...
-
- Kohn LT, et al., editors. Institute of Medicine (US) Committee on Quality of Health Care in America, editors. To err is human: building a safer health system. Washington, DC: The National Academies Press; 2000. pp. 1–312. - PubMed
-
- Hallworth MJ. The “70% claim”: what is the evidence? Ann Clin Biochem. 2011;48:487–488. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical